Concepedia

Laurie Graham

LG

Statistics

Publications

10

Citations

638

H-Index

10

Active since

1997

Affiliations

Center for Biologics Evaluation and Research(Current)

Center for Drug Evaluation and Research

United States Food and Drug Administration

National Institutes of Health

University of Chieti-Pescara

Laurie Graham is an author at Center for Biologics Evaluation and Research specializing in life sciences, signal transduction, and cell signaling.

Publications per year

1997–2017

10

Publications

10

U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab

Maitreyee Hazarika, Meredith K. Chuk, Marc R. Theoret et al. · Clinical Cancer Research · 2017 · 182 citations

, , +17

First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer

Gideon M. Blumenthal, Nancy S. Scher, Patricia Cortazar et al. · Clinical Cancer Research · 2013 · 120 citations

, , +16

Membrane Raft-Dependent Regulation of Phospholipase Cγ-1 Activation in T Lymphocytes

Maria-Concetta Verı́, Karen E. DeBell, Maria‐Cristina Seminario et al. · Molecular and Cellular Biology · 2001 · 63 citations · Full text

, , +17

Cbl-mediated Regulation of T Cell Receptor-induced AP1 Activation

Barbara L. Rellahan, Laurie Graham, Bogdan A. Stoica et al. · Journal of Biological Chemistry · 1997 · 59 citations · Full text

, , +17

The Amino-Terminal Src Homology 2 Domain of Phospholipase Cγ1 Is Essential for TCR-Induced Tyrosine Phosphorylation of Phospholipase Cγ1

Bogdan A. Stoica, Karen E. DeBell, Laurie Graham et al. · The Journal of Immunology · 1998 · 55 citations · Full text

, , +17

1–5 of 10